NCT02399852View on ClinicalTrials.gov

Effects of Lomitapide on Carotid and Aortic Atherosclerosis

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

June 30, 2015

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2021

Conditions
Homozygous Familial Hypercholesterolemia
Interventions
DRUG

Lomitapide

Sponsors
All Listed Sponsors
lead

Aegerion Pharmaceuticals, Inc.

INDUSTRY

NCT02399852 - Effects of Lomitapide on Carotid and Aortic Atherosclerosis | Biotech Hunter | Biotech Hunter